Kalocyte
Biotechnology, Emergency Medicine, Health Care
Founded in 1/1/16
Baltimore, Maryland, United States
For Profit
About Kalocyte
Kalocyte is a pre-clinical stage healthcare biotech startup company that provides artificial red blood cell substitutes used for trauma care related services. The company develops a demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable, or in short supply. Kalocyte was founded in 2016 and is headquartered in Baltimore, Maryland.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 1473000 USD
- Last Funding: None (Seed)
- Funding Status: Seed
Technology Stack
Kalocyte actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Emergency Medicine, Health Care
Headquarters: Baltimore, Maryland, United States
Leadership
- Elaine Haynes - President and CEO LinkedIn